Annual Current Liabilities
$15.99 M
+$6.50 M+68.55%
December 31, 2023
Summary
- As of February 7, 2025, CABA annual total current liabilities is $15.99 million, with the most recent change of +$6.50 million (+68.55%) on December 31, 2023.
- During the last 3 years, CABA annual current liabilities has risen by +$10.81 million (+208.76%).
- CABA annual current liabilities is now at all-time high.
Performance
CABA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$22.88 M
+$4.98 M+27.84%
September 30, 2024
Summary
- As of February 7, 2025, CABA quarterly total current liabilities is $22.88 million, with the most recent change of +$4.98 million (+27.84%) on September 30, 2024.
- Over the past year, CABA quarterly current liabilities has increased by +$4.91 million (+27.32%).
- CABA quarterly current liabilities is now at all-time high.
Performance
CABA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CABA Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +68.5% | +27.3% |
3 y3 years | +208.8% | +279.9% |
5 y5 years | +1596.1% | +646.8% |
CABA Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +90.9% | at high | +294.4% |
5 y | 5-year | at high | +408.2% | at high | +627.1% |
alltime | all time | at high | +6297.6% | at high | +2326.5% |
Cabaletta Bio Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $22.88 M(+27.8%) |
Jun 2024 | - | $17.90 M(-0.4%) |
Mar 2024 | - | $17.97 M(+12.4%) |
Dec 2023 | $15.99 M(+68.6%) | $15.99 M(+50.7%) |
Sep 2023 | - | $10.62 M(+25.2%) |
Jun 2023 | - | $8.48 M(-8.8%) |
Mar 2023 | - | $9.30 M(-1.9%) |
Dec 2022 | $9.49 M(+13.2%) | $9.49 M(+63.6%) |
Sep 2022 | - | $5.80 M(-10.6%) |
Jun 2022 | - | $6.49 M(-6.5%) |
Mar 2022 | - | $6.93 M(-17.2%) |
Dec 2021 | $8.38 M | $8.38 M(+39.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $6.02 M(+7.5%) |
Jun 2021 | - | $5.60 M(+41.1%) |
Mar 2021 | - | $3.97 M(-23.4%) |
Dec 2020 | $5.18 M(+64.6%) | $5.18 M(+21.5%) |
Sep 2020 | - | $4.26 M(+30.7%) |
Jun 2020 | - | $3.26 M(+0.2%) |
Mar 2020 | - | $3.26 M(+3.5%) |
Dec 2019 | $3.15 M(+233.7%) | $3.15 M(+2.7%) |
Sep 2019 | - | $3.06 M(+63.3%) |
Jun 2019 | - | $1.88 M(+98.9%) |
Dec 2018 | $943.00 K(+277.2%) | $943.00 K |
Dec 2017 | $250.00 K | - |
FAQ
- What is Cabaletta Bio annual total current liabilities?
- What is the all time high annual current liabilities for Cabaletta Bio?
- What is Cabaletta Bio annual current liabilities year-on-year change?
- What is Cabaletta Bio quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cabaletta Bio?
- What is Cabaletta Bio quarterly current liabilities year-on-year change?
What is Cabaletta Bio annual total current liabilities?
The current annual current liabilities of CABA is $15.99 M
What is the all time high annual current liabilities for Cabaletta Bio?
Cabaletta Bio all-time high annual total current liabilities is $15.99 M
What is Cabaletta Bio annual current liabilities year-on-year change?
Over the past year, CABA annual total current liabilities has changed by +$6.50 M (+68.55%)
What is Cabaletta Bio quarterly total current liabilities?
The current quarterly current liabilities of CABA is $22.88 M
What is the all time high quarterly current liabilities for Cabaletta Bio?
Cabaletta Bio all-time high quarterly total current liabilities is $22.88 M
What is Cabaletta Bio quarterly current liabilities year-on-year change?
Over the past year, CABA quarterly total current liabilities has changed by +$4.91 M (+27.32%)